Combined with the elevated TGF-β levels in MDD patients with SI and the potential diagnostic value of TGF-β in separating MDD patients with SI in the present study, these findings provide more data linking peripheral TGF-β to the disease severity and SI in MDD. This evidence concerns the gene TGFB1 and major depressive disorder.